Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
NCT07427797

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Led by Ipsen · Updated on 2026-04-30

300

Participants Needed

23

Research Sites

71 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the effectiveness and safety of IPN10200 compared to placebo in the improvement of the appearance of moderate to severe glabellar lines in adult participants. Glabellar lines are wrinkle-like lines that appear between the eyebrows and can become more noticeable with age or repeated facial expressions. They may affect a person's appearance and confidence. In this study, all participants will receive a single injection of either IPN10200 or placebo (the study drug). There will be 3 periods in this study: * A screening period (up to 20 days) to assess whether the participant can take part, requiring at least 1 visit to the study centre. * A treatment period (Day 1) where all the eligible participants will receive a single injection of IPN10200 or placebo. * A follow-up period (52 weeks) where participants' health will be monitored, consisting of regular visits to the study centre and 1 telephone call visit. Participants will undergo health measurements and observation, including blood sampling, physical examinations, clinical evaluations and electrocardiograms (ECG: recording of the electrical activity of heart). They will also be asked to fill in questionnaires and keep a diary. Each participant will be in this study for up to 55 weeks. Participants may withdraw consent to participate at any time.

CONDITIONS

Official Title

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be male or female aged 18 years or older at the time of consent.
  • Have moderate or severe glabellar lines at maximum frown at baseline as assessed by validated scales.
  • Be dissatisfied or very dissatisfied with their lines at baseline.
  • Female participants must use contraception consistent with local regulations.
  • Able to provide signed informed consent and comply with study requirements.
  • Have the time and ability to complete the study and follow instructions.
  • Not reside in an institution by administrative or court order.
  • Not be a sponsor employee, clinical research personnel, or immediate family member of such personnel.
Not Eligible

You will not qualify if you...

  • Active infection or skin problems in the upper face including the glabellar area.
  • History of eyelid blepharoplasty, brow lift, or other upper facial surgery within 5 years.
  • History of facial nerve palsy.
  • Marked facial asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin.
  • Scars, piercings, or tattoos near the treatment area within 6 months that could interfere with evaluations.
  • Medical conditions increasing risk with botulinum toxin exposure (e.g., myasthenia gravis).
  • Botulinum toxin treatment within 9 months prior to study or previous IPN10200 use.
  • Use of medications affecting neuromuscular transmission or aminoglycoside antibiotics within 30 days prior to baseline.
  • Use of systemic retinoids within 30 days prior to baseline and planned use during study.
  • Prior permanent or non-permanent facial treatments in the upper face within specified time frames.
  • Planned cosmetic or aesthetic procedures during the study that could interfere with evaluations.
  • Past surgery in the upper facial lines area.
  • Use of experimental drugs or devices within specified time frames.
  • Known positive for hepatitis B, hepatitis C, HIV, or AIDS diagnosis.
  • Significant psychiatric disorders interfering with participation.
  • Inability to substantially lessen glabellar lines.
  • Allergy or hypersensitivity to botulinum toxin or IPN10200 ingredients.
  • History of chronic or recreational drug abuse.
  • Uncontrolled systemic disease or significant medical condition harmful to participation.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 23 locations

1

Skin Wellness Dermatology - Homewood

Birmingham, Alabama, United States, 35209

Actively Recruiting

2

Advanced Research Associates

Glendale, Arizona, United States, 85308

Actively Recruiting

3

Avacare

Scottsdale, Arizona, United States, 85260

Not Yet Recruiting

4

Investigate MD, LLC

Scottsdale, Arizona, United States, 85260

Actively Recruiting

5

Ablon Skin Institute and Research Center

Manhattan Beach, California, United States, 90266

Actively Recruiting

6

Keith A. Marcus, MD Inc

Redondo Beach, California, United States, 90277

Actively Recruiting

7

West Dermatology

San Diego, California, United States, 92121

Not Yet Recruiting

8

Ava T. Shamban, M.D., Inc.

Santa Monica, California, United States, 90404

Actively Recruiting

9

Art of Skin MD

Solana Beach, California, United States, 92075

Actively Recruiting

10

Pacific Clinical Innovations Inc.

Vista, California, United States, 92083

Actively Recruiting

11

Skin Research Institute

Coral Gables, Florida, United States, 33146

Actively Recruiting

12

ICON Dermatology and Aesthetics

Bethesda, Maryland, United States, 20852

Actively Recruiting

13

Clinical Research Center of the Carolinas

Charleston, South Carolina, United States, 29407

Not Yet Recruiting

14

Westlake Dermatology & Cosmetic Surgery - Westlake

Austin, Texas, United States, 78746-5059

Actively Recruiting

15

Dermatology and Laser Surgery Center

Houston, Texas, United States, 77004

Actively Recruiting

16

Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research

Pflugerville, Texas, United States, 78660

Actively Recruiting

17

SkinDC

Arlington, Virginia, United States, 22209

Actively Recruiting

18

Carruthers and Humphrey Cosmetic Medicine

Vancouver, British Columbia, Canada, V5Z 4E1

Actively Recruiting

19

Pacific Dermaesthetics Inc.

Vancouver, British Columbia, Canada, V6H4E1

Not Yet Recruiting

20

Institute of Cosmetic and Laser Surgery

Oakville, Ontario, Canada, L6J 7W5

Actively Recruiting

21

Sweat clinics of canada

Toronto, Ontario, Canada, M5R 3N8

Actively Recruiting

22

Bertucci MedSpa

Woodbridge, Ontario, Canada, L4L 8E2

Not Yet Recruiting

23

Centre de Recherche Dermatologique de Quebec

Québec, Quebec, Canada, G1V4X7

Not Yet Recruiting

Loading map...

Research Team

I

Ipsen Recruitment Enquiries

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows | DecenTrialz